Polynovo Ltd (PNV)

Currency in AUD
1.040
+0.010(+0.97%)
Closed·
Advertisement
PNV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.0131.090
52 wk Range
0.8101.665
Key Statistics
Bid/Ask
1.015 / 1.04
Prev. Close
1.03
Open
1.015
Day's Range
1.013-1.09
52 wk Range
0.81-1.665
Volume
1.86M
Average Volume (3m)
2.65M
1-Year Change
-20.9125%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PNV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.297
Upside
+24.74%
Members' Sentiments
Bearish
Bullish
ProTips
Cash flows can sufficiently cover interest payments

Polynovo Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.297
(+24.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Hold0.95-8.65%1.58Downgrade29/07/2026
Canaccord Genuity
Buy1.58+51.92%1.62Maintain23/02/2026

Polynovo Ltd Earnings Call Summary for H2/2026

  • PolyNovo reported FY 2026 sales of AUD 138M (up 16.7% reported, 21.3% constant currency) with adjusted EBITDA rising 50% to AUD 13.4M.
  • U.S. sales reached AUD 102M with 200 new hospital accounts added; NovoSorb MTX sales nearly doubled to AUD 12.6M from AUD 6.7M prior year.
  • Operating cash flow surged to AUD 23.1M from AUD 3.1M; gross margin held at 89%, expected to remain 90-95% until new facility impacts margins.
  • Company targets PMA submission by end of calendar 2027 with 12-month FDA review expected; SynPath U.S. launch planned for FY 2027 with HCPCS code secured.
  • Shares fell 8% to $0.975 despite strong results, reflecting investor concerns about execution risk, lumpy burn demand, and competitive pressures in wound care.
Last Updated: 26/08/2026, 02:44
Read Full Transcript

Earnings

Latest Release
25/08/2026
EPS / Forecast
0.01 / --
Revenue / Forecast
79.52M / 83M
EPS Revisions
Last 90 days

Compare PNV to Peers and Sector

Metrics to compare
PNV
Peers
Sector
Relationship
P/E Ratio
97.9x−2.4x−0.4x
PEG Ratio
−2.20−0.030.00
Price/Book
7.9x2.1x2.6x
Price / LTM Sales
4.8x1.7x3.1x
Upside (Analyst Target)
15.8%94.4%48.2%
Fair Value Upside
Unlock20.3%6.5%Unlock

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
81.42M11.79%84.68M
Other Institutional Investors
185.88M26.91%193.32M
Public Companies & Retail Investors
423.54M61.31%440.48M
Total
690.84M100.00%718.48M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Fidelity International Ltd8.64%59,701,78262,090
UBS Asset Management AG5.42%37,417,00038,914

People Also Watch

17.230
CMM
-0.69%
6.840
CYL
+1.94%
2.880
PNR
+5.88%
0.56
ARX
+1.80%

FAQ

What Is the Polynovo (Sydney: PNV) Share Price Today?

The Polynovo stock price today is 1.040 AUD.

What Stock Exchange Does Polynovo (PNV) Trade On?

Polynovo is listed and trades on the Sydney Stock Exchange.

What Is the Ticker (Stock Symbol) for Polynovo?

The stock symbol (also called a 'ticker') for Polynovo is "PNV."

What Is the Current Polynovo Market Capitalisation?

As of today, Polynovo (Sydney: PNV) market cap is 718.480M AUD.

What Is Polynovo's (PNV) Earnings Per Share (TTM)?

The Polynovo EPS is currently 0.011 (Trailing Twelve Months).

When Is the Next Polynovo Earnings Date?

Polynovo's next earnings report will be released on 21/08/2026.

Is PNV a Buy or Sell From a Technical Analyst Perspective?

Based on today's Polynovo moving averages and other technical indicators, the daily buy/sell signal for PNV stock is Strong Buy.

How Many Times Has Polynovo Stock Split?

Polynovo has split 0 times. (See the PNV stock split history page for full effective split date and price information.)

How Many Employees Does Polynovo Have?

Polynovo has 301 employees, based on their latest Companies House report.

What is the current trading status of Polynovo (Sydney: PNV)?

As of 29/08/2026, Polynovo (PNV) is trading at a share price of 1.040 AUD, with a previous close of 1.030 AUD. The stock has fluctuated within a day range of 1.013 AUD to 1.090 AUD, while its 52-week range spans from 0.810 AUD to 1.665 AUD.

What Is Polynovo (PNV) Price Target According to Analysts?

The average 12-month price target for Polynovo is 1.297 AUD, with a high estimate of 2.1 AUD and a low estimate of 0.95 AUD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +24.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.